Studies have investigated the efficacy of serum VEGF-A levels as prognostic markers in Epithelial ovarian cancer (EOC) patients, the experiment confirmed that the OS of patients with high VEGF-A level was significantly lower than that of patients with low VEGF-A level, and the difference was statistically significant (P=0.015). The gene discussed is VEGFA; the disease is ovarian carcinoma.